GHGehane M. Hamed

Gehane M. Hamed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gehane M. Hamed has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Possible Protective Effects of Stem Cells Treatment on Ischemic/Reperfused Hearts in Hypertensive Rats Model

    by Gehane M Hamed, Manal S Abd-El Hamid, Einas M Nagib, Hanaa Ahmed Amer, Nahla Mohamed Hussien

    Back Ground: Hypertension and its cardiovascular complications as myocardial infarction are the leading causes of morbidity and mortality worldwide. Reperfusion strategies are the current standard therapy but they result in cardiac ischemia reperfusion injury. Stem cell transplantation has emerged as a promising therapeutic strategy and showed many beneficial effects in different medical disorders as reno-vascular hypertension. Aim of Work: To assess the possible protective effects of bone marrow derived mesemchymal stem cells treatment on ischemic/reperfused hearts in hypertensive rats. Materials & Methods: 49 adult female Wistar albino rats, were allocated into three main groups: control group, hypertensive untreated (Ht-u) group and hypertensive stem cells (Ht-SCs) treated group. Body weight, arterial blood pressure, ECG recording, isolated heart study with exposure to ischemia reperfusion injury and fluorescence imaging of labeled MSCs in the heart, aorta and liver were performed. Plasma lipid profile, nitric oxide, MDA and SOD levels and cardiac MDA and SOD levels were estimated. Cardiac tissues were weighed. Heart, aorta and liver were histopathologically assessed. Results: Ht-SCs treated group demonstrated significant increase in body weight gain %, significant decrease in R voltage, SBP, DBP and MAP sixth week values compared to HT-u group, with DBP and MAP showing non-significance from the control. Significant increase in heart rate basal and all reperfusion values and non-significant increase in basal PT/LVW were detected compared to HT-u group. Basal TPT and HRT were significantly shortened and MFR/LVW was significantly increased than HT-u group, being non-significantly changed from the control denoting systolic and diastolic function improvement.TPT and HRT prolongation and MFR/LVW decrease after IR injury was significantly lower in HT-SC group than HT-u group. This was accompanied by significant decrease in atherogenic index, plasma and cardiac MDA and significant increase in plasma nitrites, SOD and cardiac SOD. BM-MScs were detected in cardiac and aortic tissues. Conclusion: Single injection of BM-MScs exerted anti-hypertensive and anti-hypertrophic effects, reduced systolic and diastolic dysfunction after ischemia reperfusion injury and improved coronary flow in hypertensive rats, through homing into aortic tissues mitigating endothelial dysfunction and exerting angiogenic effects and homing into cardiac tissues exerting anti-oxidant, anti-inflammatory and anti-apoptotic effects.

  • Open Access

    Comparative study between the effect of mesenchymal stem cells and/or platelet-rich plasma on bone parameters in ovariectomized mature rats

    by Gehane M Hamed, Noha A Nassef, Rania S.A Eissa, Mona K.E Shawky, Asmaa A Abo Zeid, Arwa A Hassan

    Background: Osteoporosis is a common bone disease and is associated with considerable morbidity and mortality. Osteoporosis occurs most frequently in postmenopausal women. The inadequacy of current treatments and their side effects have driven a search for improved methods of dealing with osteoporosis. Design: Experimental study. Aim of Work: This study was conducted to throw light on the ability of BM-MSCs and/or PRP in improving bone formation and slow down bone loss in ovariectomized rats with osteoporosis. Materials & Methods: This study was carried out on adult female Wistar rats allocated randomly into five groups: Sham-operated, OVX untreated, OVX-MSCs treated (MSCs administered once intravenously), OVX/PRP treated (PRP administered once subcutaneously), OVX-MSCs/PRP treated groups. Rats were subjected to assessment of serum ALK, CTX-1, MDA and TNF-α. In addition, specimens of tibia were taken and processed for light microscopic studies and morphometric analysis. Results: OVX untreated group showed significant increases in serum levels of ALK and CTX-1. Significant elevations of serum MDA and TNF-α levels were also noticed in the OVX untreated group. Administration of BM-MSCs and PRP significantly lowered serum levels of ALK, CTX-1, MDA and TNF-α. These results were confirmed by the histopathological findings. Conclusion: BM-MSCs together with PRP can partially reverse OVX-induced bone loss and halt osteoporosis progression. Abbreviations: BM-MSCs: bone marrow derived mesenchymal stem cells, PRP: platelet-rich plasma, OVX: ovariectomized, ALK: alkaline phosphatase, CTX-1: cross linked c telopeptide of type 1 collagen, MDA: malondialdehyde, TNF-α: tumour necrosis factor-alpha.

  • POSSIBLE PROTECTIVE EFFECT OF CARNOSINE ON CADMIUM-INDUCED RENAL DYSFUNCTION IN OLD RATS

    by Gehane M. Hamed, Ansam A. Seif, Doaa Moahmmed Abdel Wahed, Ibrahim Saleh Mohammed

    Background: L-carnosine can suppress increased renal sympathetic nerve activity (SNA) during the renal ischemia by its action on the central nervous system and that this suppressive effect is probably responsible for the renoprotection against ischemic/reperfusion induced renal injury. In addition, the renoprotective effect of L-carnosine on ischemic acute renal failure seems to be induced by its conversion to L-histidine and L-histamine, and it is mediated through the activation of histamine H3 receptors in the central nervous system. Objective: Studying the effect of carnosine as a potential antioxidant agent on cadmium–induced lipid peroxidation and renal oxidative stress in aged rats. Materials and Methods: The present study was performed on 45 aged female Wistar rats, weighing at the start of the study between 280-380 g. Animals were randomly divided into the following equal groups: Control group, Cadmium group, and Carnosine treated group. Blood samples were collected and were subjected to measurement of serum urea, creatinine, albumin, malondialdehyde (MDA), superoxide dismutase (SOD), nitric oxide (NO) levels, tumor necrosis factor-α (TNF-α), interleukin10 (IL-10) levels, renal tissue tumor necrosis factor-α (TNF-α), superoxide dismutase (SOD), nitric oxide (NO) levels and measurement of cadmium (Cd) level in blood and renal tissue. Also, histopathological study of rat kidneys was performed. Results: Significant increases in serum urea and creatinine, MDA, IL10, serum and renal tissue NO, TNF -α, blood and renal tissue cadmium levels were encountered in cadmium group compared to control group. Carnosine treatment significantly decreased serum urea, creatinine, MDA, IL10, serum and renal tissue NO, TNF -α, blood and renal tissue cadmium levels compared to cadmium group though the levels were still significantly higher than control group. Serum albumin, serum and renal tissue SOD levels significantly decreased in cadmium group compared to control group. By treatment with carnosine, significant increases were observed compared to cadmium group though still significantly less compared to control group. Conclusion: Increased lipid peroxides induced by cadmium toxicity in aged rats may implicate the renal oxidative stress. Moreover, pretreatment with carnosine successively boosted the antioxidant system through several mechanisms such as scavenging/neutralizing free radicals, regulating enzymatic/non enzymatic antioxidants. However, future work is needed to confirm our results.